Hantaviral mechanisms driving HLA class I antigen presentation require both RIG-I and TRIF

European Journal of Immunology

Volumn 43, Issue 10, 2013, Pages 2566-2576

  Lalwani, Pritesh ^a,f   Raftery, Martin J ^a   Kobak, Lidija ^a   Rang, Andreas ^a   Giese, Thomas ^b   Matthaei, Markus ^c,g   van den Elsen, Peter J ^d,e   Wolff, Thorsten ^c   Krüger, Detlev H ^a   Schönrich, Günther ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c ROBERT KOCH INSTITUTE   (Germany)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^f FEDERAL UNIVERSITY OF AMAZONAS   (Brazil)

^g CSIRO   (Australia)

Author keywords

Antigen presentation processing; Cross presentation priming; Immunopathology; Infectious diseases; Innate immunity

Indexed keywords

ADAPTOR PROTEIN; ALPHA INTERFERON; BETA INTERFERON; CD8 ANTIGEN; HLA A ANTIGEN; HLA ANTIGEN CLASS 1; HLA B ANTIGEN; HLA C ANTIGEN; HLA E ANTIGEN; HLA F ANTIGEN; HLA G ANTIGEN; MYELOID DIFFERENTIATION FACTOR 88; PROTEASOME; RETINOIC ACID INDUCIBLE GENE I; RETINOIC ACID INDUCIBLE PROTEIN I; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; UNCLASSIFIED DRUG;

ANTIGEN PRESENTATION; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CROSS PRESENTATION; HANTAVIRUS; HANTAVIRUS INFECTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOMODULATION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; TISSUE INJURY; TRANSACTIVATION; UPREGULATION;

ANTIGEN PRESENTATION/PROCESSING; CROSS-PRESENTATION/PRIMING; IMMUNOPATHOLOGY; INFECTIOUS DISEASES; INNATE IMMUNITY;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; ANIMALS; ANTIGEN PRESENTATION; ATP-BINDING CASSETTE TRANSPORTERS; CERCOPITHECUS AETHIOPS; CROSS-PRIMING; DENDRITIC CELLS; HANTAVIRUS; HANTAVIRUS INFECTIONS; HLA ANTIGENS; HUMANS; PROTEASOME ENDOPEPTIDASE COMPLEX; RECEPTORS, RETINOIC ACID; RNA, SMALL INTERFERING; UP-REGULATION; VERO CELLS;

EID: 84885796366     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201243066     Document Type: Article

References (49)

1. Keesing, F., Belden, L. K., Daszak, P., Dobson, A., Harvell, C. D., Holt, R. D., Hudson, P. et al., Impacts of biodiversity on the emergence and transmission of infectious diseases. Nature 2010. 468: 647-652.
2. Klempa, B., Hantaviruses and climate change. Clin. Microbiol. Infect. 2009. 15: 518-523.
3. Nichol, S. T., Arikawa, J. and Kawaoka, Y., Emerging viral diseases. Proc. Natl. Acad. Sci. USA 2000. 97: 12411-12412.
4. Faber, M. S., Ulrich, R. G., Frank, C., Brockmann, S. O., Pfaff, G. M., Jacob, J., Kruger, D. H. et al., Steep rise in notified hantavirus infections in Germany, April 2010. Euro Surveill. 2010. 15: 19574.
5. Balabanova, Y., Gilsdorf, A., Buda, S., Burger, R., Eckmanns, T., Gartner, B., Gross, U. et al., Communicable diseases prioritized for surveillance and epidemiological research: results of a standardized prioritization procedure in Germany, 2011. PLoS ONE 2011. 6: e25691.
6. Schmaljohn, C. S. and Nichol, S. T., Bunyaviridae. In Knipe, D. M. and Howley, P. M. (Eds.), Fields virology, Lippencott Williams & Wilkins, Philadelphia, PA 2007, pp. 1741-1789.
7. Schmaljohn, C., Vaccines for hantaviruses. Vaccine 2009. 27(Suppl 4): D61-D64.
8. Kruger, D. H., Schonrich, G. and Klempa, B., Human pathogenic hantaviruses and prevention of infection. Hum. Vaccin. 2011. 7: 685-693.
9. Schonrich, G., Rang, A., Lutteke, N., Raftery, M. J., Charbonnel, N. and Ulrich, R. G., Hantavirus-induced immunity in rodent reservoirs and humans. Immunol. Rev. 2008. 225: 163-189.
10. Terajima, M. and Ennis, F. A., T cells and pathogenesis of hantavirus cardiopulmonary syndrome and hemorrhagic fever with renal syndrome. Viruses 2011. 3: 1059-1073.
11. Björkström, N. K., Lindgren, T., Stoltz, M., Fauriat, C., Braun, M., Michaëlsson, J., Klingström, J. et al., Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus. J. Exp. Med. 2010. 208: 13-21.
12. Lindgren, T., Ahlm, C., Mohamed, N., Evander, M., Ljunggren, H. G. and Bjorkstrom, N. K., Longitudinal analysis of the human T cell response during acute hantavirus infection. J. Virol. 2011. 85: 10252-10260.
13. Manigold, T., Mori, A., Graumann, R., Llop, E., Simon, V., Ferres, M., Valdivieso, F. et al., Highly differentiated, resting Gn-specific memory CD8+ T cells persist years after infection by andes hantavirus. PLoS Pathog. 2010. 6: e1000779.
14. Van Epps, H. L., Terajima, M., Mustonen, J., Arstila, T. P., Corey, E. A., Vaheri, A. and Ennis, F. A., Long-lived memory T lymphocyte responses after hantavirus infection. J. Exp. Med. 2002. 196: 579-588.
15. Kurts, C., Robinson, B. W. and Knolle, P. A., Cross-priming in health and disease. Nat. Rev. Immunol. 2010. 10: 403-414.
16. Cunningham, A. L., Donaghy, H., Harman, A. N., Kim, M. and Turville, S. G., Manipulation of dendritic cell function by viruses. Curr. Opin. Microbiol. 2010. 13: 524-529.
17. Pichlmair, A. and Reis e Sousa, C., Innate recognition of viruses. Immunity 2007. 27: 370-383.
18. Handke, W., Oelschlegel, R., Frank, R., Kruger, D. H. and Rang, A., Hantaan virus triggers TLR3-dependent innate immune responses. J. Immunol. 2009. 182: 2849-2858.
19. Jiang, H., Wang, P. Z., Zhang, Y., Xu, Z., Sun, L., Wang, L. M., Huang, C. X. et al., Hantaan virus induces toll-like receptor 4 expression, leading to enhanced production of beta interferon, interleukin-6 and tumor necrosis factor-alpha. Virology 2008. 380: 52-59.
20. Yu, H. T., Jiang, H., Zhang, Y., Nan, X. P., Li, Y., Wang, W., Jiang, W. et al., Hantaan virus triggers TLR4-dependent innate immune responses. Viral Immunol. 2012. 25: 387-393.
21. Lee, M. H., Lalwani, P., Raftery, M. J., Matthaei, M., Lutteke, N., Kirsanovs, S., Binder, M. et al., RNA helicase retinoic acid-inducible gene I as a sensor of Hantaan virus replication. J. Gen. Virol. 2011. 92: 2191-2200.
22. O'Neill, L. A. and Bowie, A. G., The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat. Rev. Immunol. 2007. 7: 353-364.
23. Raftery, M. J., Kraus, A. A., Ulrich, R., Kruger, D. H. and Schonrich, G., Hantavirus infection of dendritic cells. J. Virol. 2002. 76: 10724-10733.
24. Frese, M., Kochs, G., Feldmann, H., Hertkorn, C. and Haller, O., Inhibition of bunyaviruses, phleboviruses, and hantaviruses by human MxA protein. J. Virol. 1996. 70: 915-923.
25. Diaz, M. O., Ziemin, S., Le Beau, M. M., Pitha, P., Smith, S. D., Chilcote, R. R. and Rowley, J. D., Homozygous deletion of the alpha- and beta 1-interferon genes in human leukemia and derived cell lines. Proc. Natl. Acad. Sci. USA 1988. 85: 5259-5263.
26. Stoltz, M. and Klingstrom, J., IFN-{alpha}/{beta}-independent induction of IFN-{lambda}1 (IL-29) in response to Hantaan virus infection. J. Virol. 2010. 84: 9140-9148.
27. Clark, K., Plater, L., Peggie, M. and Cohen, P., Use of the pharmacological inhibitor BX795 to study the regulation and physiological roles of TBK1 and IkappaB kinase epsilon: a distinct upstream kinase mediates Ser-172 phosphorylation and activation. J. Biol. Chem. 2009. 284: 14136-14146.
28. Pindel, A. and Sadler, A., The role of protein kinase R in the interferon response. J. Interferon Cytokine Res. 2011. 31: 59-70.
29. Abele, R. and Tampe, R., Modulation of the antigen transport machinery TAP by friends and enemies. FEBS Lett. 2006. 580: 1156-1163.
30. Jamaluddin, M., Wang, S., Garofalo, R. P., Elliott, T., Casola, A., Baron, S. and Brasier, A. R., IFN-beta mediates coordinate expression of antigen-processing genes in RSV-infected pulmonary epithelial cells. Am. J. Physiol. Lung Cell Mol. Physiol. 2001. 280: L248-L257.
31. Momburg, F., Mullbacher, A. and Lobigs, M., Modulation of transporter associated with antigen processing (TAP)-mediated peptide import into the endoplasmic reticulum by flavivirus infection. J. Virol. 2001. 75: 5663-5671.
32. Mullbacher, A. and Lobigs, M., Up-regulation of MHC class I by flavivirus-induced peptide translocation into the endoplasmic reticulum. Immunity 1995. 3: 207-214.
33. Shim, S. H., Park, M. S., Moon, S., Park, K. S., Song, J. W., Song, K. J. and Baek, L. J., Comparison of innate immune responses to pathogenic and putative non-pathogenic hantaviruses in vitro. Virus Res. 2011. 160: 367-373.
34. Klempa, B., Witkowski, P. T., Popugaeva, E., Auste, B., Koivogui, L., Fichet-Calvet, E., Strecker, T. et al., Sangassou virus, the first hantavirus isolate from Africa, displays genetic and functional properties distinct from those of other murinae-associated hantaviruses. J. Virol. 2012. 86: 3819-3827.
35. Kraus, A. A., Raftery, M. J., Giese, T., Ulrich, R., Zawatzky, R., Hippenstiel, S., Suttorp, N. et al., Differential antiviral response of endothelial cells after infection with pathogenic and nonpathogenic hantaviruses. J. Virol. 2004. 78: 6143-6150.
36. Kesson, A. M., Cheng, Y. and King, N. J., Regulation of immune recognition molecules by flavivirus, West Nile. Viral Immunol. 2002. 15: 273-283.
37. Cheng, Y., King, N. J. and Kesson, A. M., Major histocompatibility complex class I (MHC-I) induction by West Nile virus: involvement of 2 signaling pathways in MHC-I up-regulation. J. Infect. Dis. 2004. 189: 658-668.
38. Taylor, S. L., Frias-Staheli, N., Garcia-Sastre, A. and Schmaljohn, C. S., Hantaan virus nucleocapsid protein binds to importin alpha proteins and inhibits tumor necrosis factor alpha-induced activation of nuclear factor kappa B. J. Virol. 2009. 83: 1271-1279.
39. Meissner, T. B., Liu, Y. J., Lee, K. H., Li, A., Biswas, A., van Eggermond, M. C., van den Elsen, P. J. et al., NLRC5 cooperates with the RFX transcription factor complex to induce MHC class I gene expression. J. Immunol. 2012. 188: 4951-4958.
40. Neerincx, A., Rodriguez, G. M., Steimle, V. and Kufer, T. A., NLRC5 controls basal MHC class I gene expression in an MHC enhanceosome-dependent manner. J. Immunol. 2012. 188: 4940-4950.
41. Joffre, O., Nolte, M. A., Sporri, R. and Reis e Sousa, C., Inflammatory signals in dendritic cell activation and the induction of adaptive immunity. Immunol. Rev. 2009. 227: 234-247.
42. Helft, J., Manicassamy, B., Guermonprez, P., Hashimoto, D., Silvin, A., Agudo, J., Brown, B. D. et al., Cross-presenting CD103+ dendritic cells are protected from influenza virus infection. J. Clin. Invest 2012. 122: 4037-4047.
43. Zhang, Z., Kim, T., Bao, M., Facchinetti, V., Jung, S. Y., Ghaffari, A. A., Qin, J. et al., DDX1, DDX21, and DHX36 helicases form a complex with the adaptor molecule TRIF to sense dsRNA in dendritic cells. Immunity 2011. 34: 866-878.
44. Heider, H., Ziaja, B., Priemer, C., Lundkvist, A., Neyts, J., Kruger, D. H. and Ulrich, R., A chemiluminescence detection method of hantaviral antigens in neutralisation assays and inhibitor studies. J. Virol. Methods 2001. 96: 17-23.
45. Kraus, A. A., Priemer, C., Heider, H., Kruger, D. H. and Ulrich, R., Inactivation of Hantaan virus-containing samples for subsequent investigations outside biosafety level 3 facilities. Intervirology 2005. 48: 255-261.
46. Lutteke, N., Raftery, M. J., Lalwani, P., Lee, M. H., Giese, T., Voigt, S., Bannert, N. et al., Switch to high-level virus replication and HLA class I upregulation in differentiating megakaryocytic cells after infection with pathogenic hantavirus. Virology 2010. 405: 70-80.
47. Gobin, S. J., van, Z. M., Woltman, A. M. and van den Elsen, P. J., Transactivation of classical and nonclassical HLA class I genes through the IFN-stimulated response element. J. Immunol. 1999. 163: 1428-1434.
48. Meng, L., Mohan, R., Kwok, B. H., Elofsson, M., Sin, N. and Crews, C. M., Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity. Proc. Natl. Acad. Sci. USA 1999. 96: 10403-10408.
49. Schwarz, K., de Giuli, R., Schmidtke, G., Kostka, S., van den Broek, M., Kim, K. B., Crews, C. M. et al., The selective proteasome inhibitors lactacystin and epoxomicin can be used to either up- or down-regulate antigen presentation at nontoxic doses. J. Immunol. 2000. 164: 6147-6157.